354 related articles for article (PubMed ID: 27909943)
1. Simulating Different Dosing Scenarios for a Child-Appropriate Valproate ER Formulation in a New Pediatric Two-Stage Dissolution Model.
Karkossa F; Krueger A; Urbaniak J; Klein S
AAPS PharmSciTech; 2017 Feb; 18(2):309-316. PubMed ID: 27909943
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Model Simulating Gastro-Intestinal Digestion in the Pediatric Population (Neonates and Young Infants).
Kamstrup D; Berthelsen R; Sassene PJ; Selen A; Müllertz A
AAPS PharmSciTech; 2017 Feb; 18(2):317-329. PubMed ID: 27796909
[TBL] [Abstract][Full Text] [Related]
3. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
[TBL] [Abstract][Full Text] [Related]
4. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
5. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
[TBL] [Abstract][Full Text] [Related]
6. Physiological Considerations and In Vitro Strategies for Evaluating the Influence of Food on Drug Release from Extended-Release Formulations.
Koziolek M; Kostewicz E; Vertzoni M
AAPS PharmSciTech; 2018 Oct; 19(7):2885-2897. PubMed ID: 30155808
[TBL] [Abstract][Full Text] [Related]
7. Individualized in vitro and in silico methods for predicting in vivo performance of enteric-coated tablets containing a narrow therapeutic index drug.
Karkossa F; Klein S
Eur J Pharm Biopharm; 2019 Feb; 135():13-24. PubMed ID: 30529296
[TBL] [Abstract][Full Text] [Related]
8. A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets.
Walsh PL; Bothe JR; Bhardwaj S; Hu M; Nofsinger R; Xia B; Persak S; Pennington J; Bak A
Drug Dev Ind Pharm; 2016; 42(5):836-44. PubMed ID: 26339722
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal release behaviour of modified-release drug products: dynamic dissolution testing of mesalazine formulations.
Goyanes A; Hatton GB; Merchant HA; Basit AW
Int J Pharm; 2015 Apr; 484(1-2):103-8. PubMed ID: 25721685
[TBL] [Abstract][Full Text] [Related]
10. Influence of Drug Properties and Formulation on In Vitro Drug Release and Biowaiver Regulation of Oral Extended Release Dosage Forms.
Lin Z; Zhou D; Hoag S; Qiu Y
AAPS J; 2016 Mar; 18(2):333-45. PubMed ID: 26769249
[TBL] [Abstract][Full Text] [Related]
11. Predicting the gastrointestinal behaviour of modified-release products: utility of a novel dynamic dissolution test apparatus involving the use of bicarbonate buffers.
Merchant HA; Goyanes A; Parashar N; Basit AW
Int J Pharm; 2014 Nov; 475(1-2):585-91. PubMed ID: 25195730
[TBL] [Abstract][Full Text] [Related]
12. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
Li ZQ; Tian S; Gu H; Wu ZG; Nyagblordzro M; Feng G; He X
AAPS PharmSciTech; 2018 May; 19(4):1882-1893. PubMed ID: 29663288
[TBL] [Abstract][Full Text] [Related]
13. A Biopredictive In Vitro Approach for Assessing Compatibility of a Novel Pediatric Hydrocortisone Drug Product within Common Pediatric Dosing Vehicles.
Wollmer E; Karkossa F; Freerks L; Hetberg AE; Neal G; Porter J; Whitaker MJ; Margetson D; Klein S
Pharm Res; 2020 Sep; 37(10):203. PubMed ID: 32968894
[TBL] [Abstract][Full Text] [Related]
14. Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model.
Wagner C; Jantratid E; Kesisoglou F; Vertzoni M; Reppas C; B Dressman J
Eur J Pharm Biopharm; 2012 Sep; 82(1):127-38. PubMed ID: 22652546
[TBL] [Abstract][Full Text] [Related]
15. Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets.
Gao Z; Ngo C; Ye W; Rodriguez JD; Keire D; Sun D; Wen H; Jiang W
J Pharm Sci; 2019 Mar; 108(3):1189-1194. PubMed ID: 30343136
[TBL] [Abstract][Full Text] [Related]
16. In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole.
Hens B; Pathak SM; Mitra A; Patel N; Liu B; Patel S; Jamei M; Brouwers J; Augustijns P; Turner DB
Mol Pharm; 2017 Dec; 14(12):4321-4333. PubMed ID: 28817288
[TBL] [Abstract][Full Text] [Related]
17. Performance Evaluation of Montelukast Pediatric Formulations: Part I-Age-Related In Vitro Conditions.
Guimarães M; Somville P; Vertzoni M; Fotaki N
AAPS J; 2022 Jan; 24(1):26. PubMed ID: 35013835
[TBL] [Abstract][Full Text] [Related]
18. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
[TBL] [Abstract][Full Text] [Related]
19. Once-a-day controlled-release dosage form of divalproex sodium II: development of a predictive in vitro drug release method.
Qiu Y; Garren J; Samara E; Cao G; Abraham C; Cheskin HS; Engh KR
J Pharm Sci; 2003 Nov; 92(11):2317-25. PubMed ID: 14603516
[TBL] [Abstract][Full Text] [Related]
20. A Biopredictive In Vitro Comparison of Oral Locally Acting Mesalazine Formulations by a Novel Dissolution Model for Assessing Intraluminal Drug Release in Individual Subjects.
Karkossa F; Klein S
J Pharm Sci; 2018 Jun; 107(6):1680-1689. PubMed ID: 29499277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
